Using DBS to Manage Parkinson's

More

A controlled study of implanted Deep Brain Stimulation (DBS) treatment for the symptoms of Parkinson's showed promising results in 15 clinical sites throughout the United States.

MedBrainPost.jpg

The use of implanted Deep Brain Stimulation (DBS) for the treatment of the symptoms of Parkinson's disease has been the focus of a lot of research activity and technological innovation over recent years. Last week, St. Jude Medical announced positive results from a controlled study of their Libra family of DBS implantable pulse generators, the results of which were published in the journal The Lancet Neurology.

The objective of the study was to evaluate the safety and effectiveness of the Libra devices in managing the symptoms of Parkinson's disease. The study was carried out on on 136 Parkinson's patients in 15 clinical sites throughout the U.S. and the primary endpoint was an increase in the duration in which patients had good control of their symptoms and motor functions.

The key findings reported in the journal article were as follows:

Both study groups reported a mean increase of good quality on time after three months, and the increase was greater in the stimulation group (4·27 h vs 1·77 h, difference 2·51 [95% CI 0·87--4·16]; p=0·003). Unified Parkinson's disease rating scale motor scores in the off-medication, on-stimulation condition improved by 39 percent from baseline (24·8 vs 40·8). Some serious adverse events occurred after DBS implantation, including infections in five (four percent) of 136 patients and intracranial haemorrhage in four (three percent) patients. Stimulation of the subthalamic nucleus was associated with dysarthria, fatigue, paraesthesias, and oedema, whereas gait problems, disequilibrium, dyskinesia, and falls were reported in both groups.

The Libra devices used in this study are essentially constant current pulse generators which deliver a fixed current 'dose' irrespective of changes in the properties of the region being stimulated. According to the company website the devices are currently available in Europe, Latin America, and Australia for managing the symptoms of PD.


This post also appears on medGadget, an Atlantic partner site.

Jump to comments
Presented by

medGadget is written by a group of MDs and biomedical engineers.

Get Today's Top Stories in Your Inbox (preview)

Tracing Sriracha's Origin to a Seaside Town in Thailand

Ever wonder how the wildly popular hot sauce got its name? It all started in Si Racha.


Elsewhere on the web

Join the Discussion

After you comment, click Post. If you’re not already logged in you will be asked to log in or register. blog comments powered by Disqus

Video

Where the Wild Things Go

A government facility outside of Denver houses more than a million products of the illegal wildlife trade, from tigers and bears to bald eagles.

Video

Adults Need Playtime Too

When was the last time you played your favorite childhood game?

Video

Is Wine Healthy?

James Hamblin prepares to impress his date with knowledge about the health benefits of wine.

Video

The World's Largest Balloon Festival

Nine days, more than 700 balloons, and a whole lot of hot air

Writers

Up
Down

More in Health

Just In